142 related articles for article (PubMed ID: 23022230)
21. Rosuvastatin improves pulse wave reflection by restoring endothelial function.
Ott C; Schneider MP; Schlaich MP; Schmieder RE
Microvasc Res; 2012 Jul; 84(1):60-4. PubMed ID: 22484031
[TBL] [Abstract][Full Text] [Related]
22. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.
Lu TM; Ding YA; Leu HB; Yin WH; Sheu WH; Chu KM
Am J Cardiol; 2004 Jul; 94(2):157-61. PubMed ID: 15246890
[TBL] [Abstract][Full Text] [Related]
23. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells.
Landsberger M; Jantzen F; Könemann S; Felix SB
Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089
[TBL] [Abstract][Full Text] [Related]
24. Dose-dependent effect of rosuvastatin treatment on urinary protein excretion.
Kostapanos MS; Milionis HJ; Saougos VG; Lagos KG; Kostara C; Bairaktari ET; Elisaf MS
J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):292-7. PubMed ID: 18172223
[TBL] [Abstract][Full Text] [Related]
25. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R
Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361
[TBL] [Abstract][Full Text] [Related]
26. Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats.
Sicard P; Acar N; Grégoire S; Lauzier B; Bron AM; Creuzot-Garcher C; Bretillon L; Vergely C; Rochette L
Br J Pharmacol; 2007 Aug; 151(7):979-86. PubMed ID: 17572703
[TBL] [Abstract][Full Text] [Related]
27. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
Die J; Wang K; Fan L; Jiang Y; Shi Z
Brain Res; 2010 Jul; 1346():251-61. PubMed ID: 20513366
[TBL] [Abstract][Full Text] [Related]
28. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
Habibi J; Whaley-Connell A; Qazi MA; Hayden MR; Cooper SA; Tramontano A; Thyfault J; Stump C; Ferrario C; Muniyappa R; Sowers JR
Endocrinology; 2007 May; 148(5):2181-8. PubMed ID: 17317778
[TBL] [Abstract][Full Text] [Related]
29. Kaempferol suppresses collagen-induced platelet activation by inhibiting NADPH oxidase and protecting SHP-2 from oxidative inactivation.
Wang SB; Jang JY; Chae YH; Min JH; Baek JY; Kim M; Park Y; Hwang GS; Ryu JS; Chang TS
Free Radic Biol Med; 2015 Jun; 83():41-53. PubMed ID: 25645952
[TBL] [Abstract][Full Text] [Related]
30. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
[TBL] [Abstract][Full Text] [Related]
31. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
[TBL] [Abstract][Full Text] [Related]
32. Chromatin remodeling by rosuvastatin normalizes TSC2-/meth cell phenotype through the expression of tuberin.
Lesma E; Ancona S; Orpianesi E; Grande V; Di Giulio AM; Gorio A
J Pharmacol Exp Ther; 2013 May; 345(2):180-8. PubMed ID: 23426956
[TBL] [Abstract][Full Text] [Related]
33. NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease.
Loffredo L; Carnevale R; Cangemi R; Angelico F; Augelletti T; Di Santo S; Calabrese CM; Della Volpe L; Pignatelli P; Perri L; Basili S; Violi F
Int J Cardiol; 2013 Apr; 165(1):184-92. PubMed ID: 22336250
[TBL] [Abstract][Full Text] [Related]
34. Rosuvastatin attenuates monocyte-endothelial cell interactions and vascular free radical production in hypercholesterolemic mice.
Li W; Asagami T; Matsushita H; Lee KH; Tsao PS
J Pharmacol Exp Ther; 2005 May; 313(2):557-62. PubMed ID: 15665143
[TBL] [Abstract][Full Text] [Related]
35. Rosuvastatin suppresses the oxidative response in the venous limb of an arteriovenous fistula and enhances the fistula blood flow in diabetic rats.
Fang SY; Roan JN; Lin Y; Hsu CH; Chang SW; Huang CC; Tsai YC; Lam CF
J Vasc Res; 2014; 51(2):81-9. PubMed ID: 24434545
[TBL] [Abstract][Full Text] [Related]
36. Not all statins interfere with clopidogrel during antiplatelet therapy.
Mach F; Senouf D; Fontana P; Boehlen F; Reber G; Daali Y; de Moerloose P; Sigwart U
Eur J Clin Invest; 2005 Aug; 35(8):476-81. PubMed ID: 16101667
[TBL] [Abstract][Full Text] [Related]
37. Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis.
Schupp N; Schmid U; Heidland A; Stopper H
Atherosclerosis; 2008 Aug; 199(2):278-87. PubMed ID: 18154958
[TBL] [Abstract][Full Text] [Related]
38. The effects of tamoxifen and its metabolites on platelet function and release of reactive oxygen intermediates.
Vitseva O; Flockhart DA; Jin Y; Varghese S; Freedman JE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1144-50. PubMed ID: 15509721
[TBL] [Abstract][Full Text] [Related]
39. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.
Kim YS; Ahn Y; Hong MH; Kim KH; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC
J Cardiovasc Pharmacol; 2007 Jun; 49(6):376-83. PubMed ID: 17577102
[TBL] [Abstract][Full Text] [Related]
40. LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism.
Carnevale R; Bartimoccia S; Nocella C; Di Santo S; Loffredo L; Illuminati G; Lombardi E; Boz V; Del Ben M; De Marco L; Pignatelli P; Violi F
Atherosclerosis; 2014 Nov; 237(1):108-16. PubMed ID: 25238217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
